Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

A total of 43 A. baumannii strains, isolated from 43 patients affected by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and by bacterial sepsis, were analyzed …

Acinetobacter baumannii is a Gram-negative coccobacillus with exceptional survival skills in
an unfavorable environment and the ability to rapidly acquire antibiotic resistance, making it …

Introduction. Carbapenem-resistant Acinetobacter baumannii (CRAB) is the primary
pathogen causing hospital-acquired infections. The spread of CRAB is mainly driven by the …

Carbapenem-resistant Acinetobacter baumannii (CR Ab) is a public health threat accounting
for a significant number of hospital-acquired infections. Despite the importance of this …

Acinetobacter baumannii is a nosocomial bacterial pathogen and is responsible for a wide
range of diseases including pneumonia, necrotizing fasciitis, meningitis, and sepsis. The …

Acinetobacter baumannii is a major public health concern, for which many genomic
epidemiology studies have been conducted in the last decade. However, the vast majority of …

Acinetobacter baumannii is a dangerous bacterial pathogen possessing the ability to persist
on various surfaces, especially in clinical settings, and to rapidly acquire the resistance to a …

Background Acinetobacter baumannii international clone II (IC2) is a widespread pandemic
clone, however, it is rarely described in South America. The present study reported an …